["{\n\"step_by_step_thinking\": \"The patient has a history of endometrial hyperplasia treated with medroxyprogesterone, which is an estrogen agonist. This increases the risk of developing breast cancer. The treatment that prevents further bone resorption and reduces the risk of developing breast cancer puts her at increased risk of deep vein thrombosis.\",\n\"answer_choice\": \"D\"\n}"]